Cases
Henry Schein, Inc. (NASDAQ: HSIC)
Securities Class Action
Overview
Overview
- Date:
- 3/9/2018
- Company Name:
- Henry Schein, Inc.
- Stock Symbol:
- HSIC
- Class Period:
- FROM 3/17/2013 TO 2/12/2018
- Status:
- Closed/Complete
- Court:
- U.S. District Court: Eastern New York
NEW YORK, March 9, 2018 – Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of all persons or entities who purchased or otherwise acquired Henry Schein, Inc. (NASDAQ: HSIC) securities between March 7, 2013 and February 12, 2018 (the “Class Period”). Investors have until May 7, 2018 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
On February 12, 2018, it was reported that the U.S. Federal Trade Commission had filed a complaint against the three largest U.S. dental supply companies, saying they had broken antitrust law. According to the complaint, Benco Dental Supply, Henry Schein Inc., and Patterson Companies conspired to refuse to serve or give discounts to dental buying groups.
Following these disclosures, the stock price of Henry Schein fell $4.79, or over 6.6% to close at $67.39 per share on February 13, 2018.
The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (1) Henry Schein was engaging in unethical, anti-competitive behavior through agreements with Benco Dental Supply Company and Patterson Companies, Inc., in violation of United States antitrust laws; (2) Henry Schein engaged in such behavior, in part, to help maintain profitability in a consolidating health care industry; (3) these violations of U.S. antitrust laws would result in heightened scrutiny by the federal government and a lawsuit filed by the Federal Trade Commission ("FTC"); (4) Henry Schein failed to maintain adequate internal controls; and (5) as a result, defendants' statements about Henry Schein's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired Henry Schein securities and suffered a loss, continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
On February 12, 2018, it was reported that the U.S. Federal Trade Commission had filed a complaint against the three largest U.S. dental supply companies, saying they had broken antitrust law. According to the complaint, Benco Dental Supply, Henry Schein Inc., and Patterson Companies conspired to refuse to serve or give discounts to dental buying groups.
Following these disclosures, the stock price of Henry Schein fell $4.79, or over 6.6% to close at $67.39 per share on February 13, 2018.
The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (1) Henry Schein was engaging in unethical, anti-competitive behavior through agreements with Benco Dental Supply Company and Patterson Companies, Inc., in violation of United States antitrust laws; (2) Henry Schein engaged in such behavior, in part, to help maintain profitability in a consolidating health care industry; (3) these violations of U.S. antitrust laws would result in heightened scrutiny by the federal government and a lawsuit filed by the Federal Trade Commission ("FTC"); (4) Henry Schein failed to maintain adequate internal controls; and (5) as a result, defendants' statements about Henry Schein's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired Henry Schein securities and suffered a loss, continue to hold shares purchased prior to the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.